Controversies in the Management of Isolated Congenital Atrioventricular Block
DeNoble AE, Kuller JA, Rhee EJ. Controversies in the Management of Isolated Congenital Atrioventricular Block. Obstetrical & Gynecological Survey 2015, 70: 518-523. PMID: 26314237, DOI: 10.1097/ogx.0000000000000208.Peer-Reviewed Original ResearchMeSH KeywordsAnti-Inflammatory AgentsAntirheumatic AgentsAtrioventricular BlockDexamethasoneFemaleHistocompatibility, Maternal-FetalHumansHydroxychloroquineImmunoglobulinsImmunologic FactorsInfant, NewbornPregnancyPrenatal DiagnosisConceptsCongenital atrioventricular blockAnti-La antibodiesAtrioventricular blockIntravenous immunoglobulinFetuses of mothersStudy of dexamethasoneTreatment of fetusesLarge prospective studiesHigh fetal morbidityPotential adverse effectsRheumatologic symptomsAnti-RoFetal morbidityAntinuclear antibodiesFetal hydropsProspective studyTreatment regimensAutoimmune diseasesRisk mothersLimited potential benefitsAdverse effectsFetusesConflicting resultsAntibodiesTreatment